11,976 Shares in Waters Corporation $WAT Acquired by Fulcrum Asset Management LLP

Fulcrum Asset Management LLP acquired a new position in Waters Corporation (NYSE:WAT) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 11,976 shares of the medical instruments supplier’s stock, valued at approximately $5,308,000.

Other institutional investors also recently bought and sold shares of the company. Ashton Thomas Securities LLC raised its holdings in shares of Waters by 3.5% in the third quarter. Ashton Thomas Securities LLC now owns 704 shares of the medical instruments supplier’s stock worth $309,000 after buying an additional 24 shares during the last quarter. Caitlin John LLC increased its position in shares of Waters by 43.9% in the second quarter. Caitlin John LLC now owns 82 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 25 shares in the last quarter. Park Avenue Securities LLC raised its position in Waters by 2.8% during the third quarter. Park Avenue Securities LLC now owns 910 shares of the medical instruments supplier’s stock worth $400,000 after acquiring an additional 25 shares during the period. Kingswood Wealth Advisors LLC raised its holdings in shares of Waters by 3.7% during the third quarter. Kingswood Wealth Advisors LLC now owns 786 shares of the medical instruments supplier’s stock valued at $345,000 after acquiring an additional 28 shares during the last quarter. Finally, Avalon Trust Co grew its holdings in shares of Waters by 2.3% during the first quarter. Avalon Trust Co now owns 1,330 shares of the medical instruments supplier’s stock worth $396,000 after buying an additional 30 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on WAT shares. Stifel Nicolaus set a $470.00 price objective on Waters in a research report on Wednesday, November 4th. Leerink Partners boosted their target price on Waters from $420.00 to $450.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Piper Sandler upgraded Waters from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $400.00 to $480.00 in a research note on Thursday, August 27th. Morgan Stanley set a $430.00 price target on Waters in a research report on Wednesday, August 5th. Finally, Wells Fargo & Company lifted their price objective on Waters from $370.00 to $400.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $475.48.

Waters Stock Up 4.3%

WAT stock opened at $477.12 on Tuesday. The company has a market cap of $46.88 billion, a price-to-earnings ratio of 204.77, a price-to-earnings-growth ratio of 2.71 and a beta of 1.16. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.66 and a quick ratio of 1.29. The company has a fifty day moving average price of $435.97 and a 200 day moving average price of $372.64. Waters Corporation has a 12 month low of $282.77 and a 12 month high of $482.28.

Waters (NYSE:WAT) last released its quarterly earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 EPS for the quarter, topping the consensus estimate of $4.00 by $0.10. The business had revenue of $1.77 billion during the quarter, compared to analysts’ expectations of $1.75 billion. Waters had a return on equity of 9.91% and a net margin of 1.75%. The company’s quarterly revenue was up 120.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.40 earnings per share. Sell-side analysts expect that Waters Corporation will post 14.65 earnings per share for the current year.

Waters Profile

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples.

The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Founded in 1958 by James L.